TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
iX Biopharma Ltd. ( (SG:42C) ) has issued an update.
iX Biopharma Ltd. has entered into a placement agreement with Oversea-Chinese Banking Corporation Limited to raise a minimum of S$5,000,000 through the issuance of new ordinary shares. This strategic move aims to enhance the company’s capital structure by offering shares that will constitute approximately 5.33% of its enlarged share capital. The placement is structured as an exempt offering in Singapore, targeting institutional and accredited investors, and is expected to bolster the company’s financial position, potentially impacting its market operations and investor relations positively.
More about iX Biopharma Ltd.
iX Biopharma Ltd. is a company incorporated in Singapore, operating in the biopharmaceutical industry. The company focuses on the development and commercialization of innovative therapies, with a particular emphasis on sublingual drug delivery systems.
Average Trading Volume: 8,678,119
Technical Sentiment Signal: Buy
Current Market Cap: S$83.55M
Learn more about 42C stock on TipRanks’ Stock Analysis page.